JMP Securities analyst Roy Buchanan reiterated a Market Outperform rating and $34.00 price target on CureVac (NASDAQ: CVAC) FDA released ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE